Wildner et al., 1997, "Database screening for molecular mimicry", Immunol. Today 18:252. |
Baum et al., 1997, "Also", Immunol. Today 18:252-253. |
Franchini et al., 1987, Nature 328:539-543. |
Chakrabarti et al., 1987, Nature 328:543-547. |
Wild et al., 1992, Proc. Natl. Acad. Sci. USA, 89:10537-10541. |
Mitsuya et al., 1991, "Targeted therapy of human immunodeficiency virus-related disease", FASEB J. 5:2369-2381. |
Hammarskjold and Rekosh, 1989, "The molecular biology of the human immunodeficiency virus", Biochem. Biophys. Acta 989:269-280. |
Guyader et al., 1987, "Genome organization and transactivation of the human immunodeficiency virus type 2", Nature 326:662-669. |
Clavel et al., 1986, "Isolation of a new human retrovirus from west african patients with AIDS", Science 233:343-346. |
Maddon et al., 1986, "The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain", Cell 47:333-348. |
McDougal et al., 1986, "Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110k viral protein and the T4 molecule", Science 231:382-385. |
Barin et al., 1985, "Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients", Science 228:1094-1096. |
Dalgleish et al., 1984, "The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus", Nature 312:763-767. |
Gallo et al., 1984, "Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS", Science 224:500-503. |
Klatzmann et al., 1984, "T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV", Nature 312:767-768. |
Teich et al., 1984, Pathogenesis of lentivirus, in "RNA Tumor Viruses", Weiss et al., eds., CSH-Press, pp. 949-956. |
Barre-Sinoussi et al., 1983, "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)", Science 220:868-870. |
Chen, 1994, "Functional role of the zipper motif region of the human immunodeficiency virus type 1 transmembrane protein gp41", J. Virology 68:2002-2010. |
Carr and Kim, 1993, "Aspring loaded mechanism for the conformation change of influenza hemagglutinin", Cell 73:823-832. |
Songyang et al., 1993, "SH2 domains recognize specific phosphopeptide sequences", Cell 72:767-778. |
Lam et al., 1991, "The new type of synthetic peptide library for identifying ligand-binding activity", Nature 354:82-84. |
Lupas et al., "Predicting coiled coils from protein sequences", Science 252:1162-1165. |
Xu et al., 1991, "Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies", J. Virology 65:4832-4838. |
Chambers et al., 1990, "Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins", J. Gen. Virology 71:3075-3080. |
Malim et al., 1988, "Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes", Nature 355:181-183. |
Suzuki et al., 1995, "Viral Interleukin 10 (IL-10), the Human Herpes Virus 4 Cellular IL-10 Homologue, Induces Local Anergy to Allogenic and Syngeneic Tumors", J of Experimental Medicine 182:477-486. |
Wild et al., 1994, "Propensity for a Leucine Zipper-Like Domain of Human Immunodeficiency Virus Type 1 gp41 to Form Oligomers Correlates With a Role in Virus-Induced Fusion Rather Than Assembly of the Glycoprotein Complex", Proc. Natl. Acad. Sci. USA 91:12676-80. |
Bousse et al., 1994, "Regions on the Hemagglutinin-Neuraminidase Proteins of Human Parainfluenza Virus Type-1 and Sendai Virus Important for Membrane Fusion", Virology 204:506-514. |
Wang et al., 1993, "Ion Channel Activity of Influenza A Virus M2 Protein: Characterization of the Amantidine Block", J of Virology 67:5585-94. |
Lazinski et al., 1993, "Relating Structure to Function in the Hepatitis Delta Virus Antigen", J of Virology 67:2672-80. |
White, J.M., 1992, "Membrane Fusion", Science 258:917-924. |
Daar et al., 1990, "High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates", Proc. Natl. Acad. Sci. USA 87:6574-6579. |
Erickson et al., 1990, "Design, Activity, and 2,8 .ANG. Crystal Structure of a C.sub.2 Symmetric Inhibitor Complexed to HIV-1 Protease", Science 249:527-533. |
Smith et al., 1987, "Blocking of HIV-1 Infectivity by a Soluble, Secreted Form of the CD4 Antigen", Science 238:1704-1707. |
Collins et al., 1984, "Nucleotide Sequence of the Gene Encoding the Fusion (F) Glycoprotein of Human Respiratory Syncytial Virus", Proc. Natl. Acad. Sci. USA 81:7683-87. |
Gallaher et al., 1989, "A General Model for the Transmembrane Proteins of HIV and Other Retroviruses", AIDS Res. and Human Retroviruses 5:431-440. |
Jiang et al., 1993, "Inhibition of HIV-1 Infection by a Fusion Domain Binding Peptide from the HIV-1 Envelope Glycoprotein gp41", Biochem. Biophys. Res. Comm. 195:533-538. |
Kingsbury, 1990, "Paramyxoviridae and Their Replication", in Virology, 2.sup.nd Edition, Fields et al., eds., Raven Press, New York, p. 951. |
Okamoto et al., 1988, "Typing Hepatitis B Virus by Homology in Nucleotide Sequence: Comparison of Surface Antigen Subtypes", J. Gen. Virol. 69:2575-2583. |
Richardson et al., 1986, "The Nucleotide Sequence of the mRNA Encoding the Fusion Protein of Measles Virus (Edmonston Strain): A Comparison of Fusion Proteins from Several Different Paramyxoviruses", Virol. 155:508-523. |
Staden, 1994, "Searching for Motifs in Protein Sequences", Chapter 12 in: Methods in Molecular Biology, vol. 25, Griffin et al., eds., Humana Press, Inc., Totowa, NJ, pp. 131-139. |
Staden, 1994, "Using Patterns to Analyze Protein Sequences", Chapter 13 in: Methods in Molecular Biology, vol. 25, Griffin et al., eds., Humana Press, Inc., Totowa, NJ, pp. 141-154. |
Staden, 1990, "Searching for Patterns in Protein and Nucleic Acid Sequences", Meth. Enzymol. 183:193-211. |
Tyler et al., 1990, "Identification of Sites Within gp41 That Serve as Targets for Antibody-Dependent Cellular Cytotoxicity by Using Human Monoclonal Antibodies", J. Immunol. 145:3276-3282. |
Wild et al., 1994, "Peptides Corresponding to a Predictive .alpha.-Helical Domain of Human Immunodeficiency Virus Type 1 gp41 Are Potent Inhibitors of Virus Infection", Proc. Natl. Acad. Sci. USA 91:9770-9774. |
Wild et al., 1993, "A Synthetic Peptide from HIV-1 gp41 is a Potent Inhibitor of Virus-Mediated Cell-Cell Fusion", AIDS Res. and Human Retroviruses 9:1051-1053. |